Cargando…
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
Fumarate hydratase (FH)-deficient kidney cancer undergoes metabolic remodeling, with changes in mitochondrial respiration, glucose, and glutamine metabolism. These changes represent multiple biochemical adaptations in glucose and fatty acid metabolism that supports malignant proliferation. However,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744468/ https://www.ncbi.nlm.nih.gov/pubmed/23967283 http://dx.doi.org/10.1371/journal.pone.0072179 |
_version_ | 1782280592513040384 |
---|---|
author | Yang, Youfeng Lane, Andrew N. Ricketts, Christopher J. Sourbier, Carole Wei, Ming-Hui Shuch, Brian Pike, Lisa Wu, Min Rouault, Tracey A. Boros, Laszlo G. Fan, Teresa W.-M. Linehan, W. Marston |
author_facet | Yang, Youfeng Lane, Andrew N. Ricketts, Christopher J. Sourbier, Carole Wei, Ming-Hui Shuch, Brian Pike, Lisa Wu, Min Rouault, Tracey A. Boros, Laszlo G. Fan, Teresa W.-M. Linehan, W. Marston |
author_sort | Yang, Youfeng |
collection | PubMed |
description | Fumarate hydratase (FH)-deficient kidney cancer undergoes metabolic remodeling, with changes in mitochondrial respiration, glucose, and glutamine metabolism. These changes represent multiple biochemical adaptations in glucose and fatty acid metabolism that supports malignant proliferation. However, the metabolic linkages between altered mitochondrial function, nucleotide biosynthesis and NADPH production required for proliferation and survival have not been elucidated. To characterize the alterations in glycolysis, the Krebs cycle and the pentose phosphate pathways (PPP) that either generate NADPH (oxidative) or do not (non-oxidative), we utilized [U-(13)C]-glucose, [U-(13)C,(15)N]-glutamine, and [1,2- (13)C(2)]-glucose tracers with mass spectrometry and NMR detection to track these pathways, and measured the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of growing cell lines. This metabolic reprogramming in the FH null cells was compared to cells in which FH has been restored. The FH null cells showed a substantial metabolic reorganization of their intracellular metabolic fluxes to fulfill their high ATP demand, as observed by a high rate of glucose uptake, increased glucose turnover via glycolysis, high production of glucose-derived lactate, and low entry of glucose carbon into the Krebs cycle. Despite the truncation of the Krebs cycle associated with inactivation of fumarate hydratase, there was a small but persistent level of mitochondrial respiration, which was coupled to ATP production from oxidation of glutamine-derived α–ketoglutarate through to fumarate. [1,2- (13)C(2)]-glucose tracer experiments demonstrated that the oxidative branch of PPP initiated by glucose-6-phosphate dehydrogenase activity is preferentially utilized for ribose production (56-66%) that produces increased amounts of ribose necessary for growth and NADPH. Increased NADPH is required to drive reductive carboxylation of α-ketoglutarate and fatty acid synthesis for rapid proliferation and is essential for defense against increased oxidative stress. This increased NADPH producing PPP activity was shown to be a strong consistent feature in both fumarate hydratase deficient tumors and cell line models. |
format | Online Article Text |
id | pubmed-3744468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37444682013-08-21 Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma Yang, Youfeng Lane, Andrew N. Ricketts, Christopher J. Sourbier, Carole Wei, Ming-Hui Shuch, Brian Pike, Lisa Wu, Min Rouault, Tracey A. Boros, Laszlo G. Fan, Teresa W.-M. Linehan, W. Marston PLoS One Research Article Fumarate hydratase (FH)-deficient kidney cancer undergoes metabolic remodeling, with changes in mitochondrial respiration, glucose, and glutamine metabolism. These changes represent multiple biochemical adaptations in glucose and fatty acid metabolism that supports malignant proliferation. However, the metabolic linkages between altered mitochondrial function, nucleotide biosynthesis and NADPH production required for proliferation and survival have not been elucidated. To characterize the alterations in glycolysis, the Krebs cycle and the pentose phosphate pathways (PPP) that either generate NADPH (oxidative) or do not (non-oxidative), we utilized [U-(13)C]-glucose, [U-(13)C,(15)N]-glutamine, and [1,2- (13)C(2)]-glucose tracers with mass spectrometry and NMR detection to track these pathways, and measured the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of growing cell lines. This metabolic reprogramming in the FH null cells was compared to cells in which FH has been restored. The FH null cells showed a substantial metabolic reorganization of their intracellular metabolic fluxes to fulfill their high ATP demand, as observed by a high rate of glucose uptake, increased glucose turnover via glycolysis, high production of glucose-derived lactate, and low entry of glucose carbon into the Krebs cycle. Despite the truncation of the Krebs cycle associated with inactivation of fumarate hydratase, there was a small but persistent level of mitochondrial respiration, which was coupled to ATP production from oxidation of glutamine-derived α–ketoglutarate through to fumarate. [1,2- (13)C(2)]-glucose tracer experiments demonstrated that the oxidative branch of PPP initiated by glucose-6-phosphate dehydrogenase activity is preferentially utilized for ribose production (56-66%) that produces increased amounts of ribose necessary for growth and NADPH. Increased NADPH is required to drive reductive carboxylation of α-ketoglutarate and fatty acid synthesis for rapid proliferation and is essential for defense against increased oxidative stress. This increased NADPH producing PPP activity was shown to be a strong consistent feature in both fumarate hydratase deficient tumors and cell line models. Public Library of Science 2013-08-15 /pmc/articles/PMC3744468/ /pubmed/23967283 http://dx.doi.org/10.1371/journal.pone.0072179 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Yang, Youfeng Lane, Andrew N. Ricketts, Christopher J. Sourbier, Carole Wei, Ming-Hui Shuch, Brian Pike, Lisa Wu, Min Rouault, Tracey A. Boros, Laszlo G. Fan, Teresa W.-M. Linehan, W. Marston Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title | Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title_full | Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title_fullStr | Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title_full_unstemmed | Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title_short | Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma |
title_sort | metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744468/ https://www.ncbi.nlm.nih.gov/pubmed/23967283 http://dx.doi.org/10.1371/journal.pone.0072179 |
work_keys_str_mv | AT yangyoufeng metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT laneandrewn metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT rickettschristopherj metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT sourbiercarole metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT weiminghui metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT shuchbrian metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT pikelisa metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT wumin metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT rouaulttraceya metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT boroslaszlog metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT fanteresawm metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma AT linehanwmarston metabolicreprogrammingforproducingenergyandreducingpowerinfumaratehydratasenullcellsfromhereditaryleiomyomatosisrenalcellcarcinoma |